- Home
- CISO vs INDP Comparison
CISO vs INDP Comparison
Compare CISO & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- INDP
- Stock Information
- Founded
- CISO 2015
- INDP 2000
- Country
- CISO United States
- INDP United States
- Employees
- CISO N/A
- INDP N/A
- Industry
- CISO Computer Software: Prepackaged Software
- INDP Biotechnology: Pharmaceutical Preparations
- Sector
- CISO Technology
- INDP Health Care
- Exchange
- CISO Nasdaq
- INDP Nasdaq
- Market Cap
- CISO 44.2M
- INDP 7.4M
- IPO Year
- CISO N/A
- INDP N/A
- Fundamental
- Price
- CISO $0.81
- INDP $0.34
- Analyst Decision
- CISO
- INDP Strong Buy
- Analyst Count
- CISO 0
- INDP 2
- Target Price
- CISO N/A
- INDP $8.50
- AVG Volume (30 Days)
- CISO 6.3M
- INDP 718.1K
- Earning Date
- CISO 05-15-2025
- INDP 05-14-2025
- Dividend Yield
- CISO N/A
- INDP N/A
- EPS Growth
- CISO N/A
- INDP N/A
- EPS
- CISO N/A
- INDP N/A
- Revenue
- CISO $29,887,603.00
- INDP N/A
- Revenue This Year
- CISO N/A
- INDP N/A
- Revenue Next Year
- CISO N/A
- INDP N/A
- P/E Ratio
- CISO N/A
- INDP N/A
- Revenue Growth
- CISO N/A
- INDP N/A
- 52 Week Low
- CISO $0.26
- INDP $0.31
- 52 Week High
- CISO $3.84
- INDP $2.89
- Technical
- Relative Strength Index (RSI)
- CISO 43.69
- INDP 37.49
- Support Level
- CISO $0.97
- INDP $0.31
- Resistance Level
- CISO $1.49
- INDP $0.40
- Average True Range (ATR)
- CISO 0.29
- INDP 0.05
- MACD
- CISO -0.04
- INDP -0.00
- Stochastic Oscillator
- CISO 14.42
- INDP 16.47
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.